The salmochelin receptor IroN itself, but not salmochelin-mediated iron uptake promotes biofilm formation in extraintestinal pathogenic Escherichia coli (ExPEC)

International Journal of Medical Microbiology

Volumn 305, Issue 4-5, 2015, Pages 435-445

  Magistro, Giuseppe ^a   Hoffmann, Christiane ^a   Schubert, Sören ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biofilm; Extraintestinal pathogenic Escherichia coli; IroN; Siderophores; Urinary tract infection

Indexed keywords

BACTERIAL PROTEIN; IRON; SALMOCHELIN RECEPTOR IRON; SIDEROPHORE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; DELETION MUTANT; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; GENE DISRUPTION; GENE EXPRESSION; GENE TARGETING; GENETIC CODE; HUMAN; IRON TRANSPORT; LABORATORY; MICROBIAL COMMUNITY; PLANKTON; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION;

EID: 84983097734     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2015.03.008     Document Type: Article

References (46)

1. Alteri C.J., Hagan E.C., Sivick K.E., Smith S.N., Mobley H.L. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 2009, 5(9):e1000586.
2. Alves J.R., Pereira A.C., Souza M.C., Costa S.B., Pinto A.S., Mattos-Guaraldi A.L., et al. Iron-limited condition modulates biofilm formation and interaction with human epithelial cells of enteroaggregative Escherichia coli (EAEC). J. Appl. Microbiol. 2010, 108(1):246-255.
3. Anderson G.G., Palermo J.J., Schilling J.D., Roth R., Heuser J., Hultgren S.J. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003, 301(5629):105-107.
4. Baumler A.J., Tsolis R.M., van der Velden A.W., Stojiljkovic I., Anic S., Heffron F. Identification of a new iron regulated locus of Salmonella typhi. Gene 1996, 183(1-2):207-213.
5. Berger H., Hacker J., Juarez A., Hughes C., Goebel W. Cloning of the chromosomal determinants encoding hemolysin production and mannose-resistant hemagglutination in Escherichia coli. J. Bacteriol. 1982, 152(3):1241-1247.
6. Bister B., Bischoff D., Nicholson G.J., Valdebenito M., Schneider K., Winkelmann G., et al. The structure of salmochelins: C-glucosylated enterobactins of Salmonella enterica. Biometals 2004, 17(4):471-481.
7. Blattner F.R., Plunkett G., Bloch C.A., Perna N.T., Burland V., Riley M., et al. The complete genome sequence of Escherichia coli K-12. Science 1997, 277(5331):1453-1462.
8. Brooks T., Keevil C.W. A simple artificial urine for the growth of urinary pathogens. Lett. Appl. Microbiol. 1997, 24(3):203-206.
9. Brumbaugh A.R., Smith S.N., Mobley H.L. Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect. Immun. 2013, 81(9):3309-3316.
10. Caza M., Lepine F., Milot S., Dozois C.M. Specific roles of the iroBCDEN genes in virulence of an avian pathogenic Escherichia coli O78 strain and in production of salmochelins. Infect. Immun. 2008, 76(8):3539-3549.
11. Chang A.C., Cohen S.N. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J. Bacteriol. 1978, 134(3):1141-1156.
12. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162(1):156-159.
13. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(12):6640-6645.
14. Durant L., Metais A., Soulama-Mouze C., Genevard J.M., Nassif X., Escaich S. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli. Infect. Immun. 2007, 75(4):1916-1925.
15. Feldmann F., Sorsa L.J., Hildinger K., Schubert S. The salmochelin siderophore receptor IroN contributes to invasion of urothelial cells by extraintestinal pathogenic Escherichia coli in vitro. Infect. Immun. 2007, 75(6):3183-3187.
16. Fischbach M.A., Lin H., Liu D.R., Walsh C.T. In vitro characterization of IroB, a pathogen-associated C-glycosyltransferase. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(3):571-576.
17. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am. J. Public Health 1990, 80(3):331-333.
18. Foxman B., Barlow R., d'Arcy H., Gillespie B., Sobel J.D. Urinary tract infection: self-reported incidence and associated costs. Ann. Epidemiol. 2000, 10(8):509-515.
19. Garenaux A., Caza M., Dozois C.M. The Ins and Outs of siderophore mediated iron uptake by extra-intestinal pathogenic Escherichia coli. Vet. Microbiol. 2011, 153(1-2):89-98.
20. Hancock V., Ferrieres L., Klemm P. The ferric yersiniabactin uptake receptor FyuA is required for efficient biofilm formation by urinary tract infectious Escherichia coli in human urine. Microbiology 2008, 154(Pt 1):167-175.
21. Hancock V., Dahl M., Klemm P. Abolition of biofilm formation in urinary tract Escherichia coli and Klebsiella isolates by metal interference through competition for fur. Appl. Environ. Microbiol. 2010, 76(12):3836-3841.
22. Hantke K., Nicholson G., Rabsch W., Winkelmann G. Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(7):3677-3682.
23. Hultgren S.J., Schwan W.R., Schaeffer A.J., Duncan J.L. Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect. Immun. 1986, 54(3):613-620.
24. Johnson J.R. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 1991, 4(1):80-128.
25. Johnson J.R., Russo T.A. Extraintestinal pathogenic Escherichia coli: the other bad E. coli. J. Lab Clin. Med. 2002, 139(3):155-162.
26. Kaper J.B., Nataro J.P., Mobley H.L. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2004, 2(2):123-140.
27. Klemm P., Hancock V., Schembri M.A. Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect. Immun. 2007, 75(8):3688-3695.
28. Kohler C.D., Dobrindt U. What defines extraintestinal pathogenic Escherichia coli?. Int. J. Med. Microbiol. 2011, 301(8):642-647.
29. Kucheria R., Dasgupta P., Sacks S.H., Khan M.S., Sheerin N.S. Urinary tract infections: new insights into a common problem. Postgrad. Med. J. 2005, 81(952):83-86.
30. Lin H., Fischbach M.A., Liu D.R., Walsh C.T. In vitro characterization of salmochelin and enterobactin trilactone hydrolases IroD, IroE, and Fes. J. Am. Chem. Soc. 2005, 127(31):11075-11084.
31. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
32. Marrs C.F., Zhang L., Foxman B. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?. FEMS Microbiol. Lett. 2005, 252(2):183-190.
33. Muller S.I., Valdebenito M., Hantke K. Salmochelin, the long-overlooked catecholate siderophore of Salmonella. Biometals 2009, 22(4):691-695.
34. Negre V.L., Bonacorsi S., Schubert S., Bidet P., Nassif X., Bingen E. The siderophore receptor IroN, but not the high-pathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitis. Infect. Immun. 2004, 72(2):1216-1220.
35. Nielubowicz G.R., Mobley H.L. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 2010, 7(8):430-441.
36. O'Toole G.A., Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 1998, 28(3):449-461.
37. Rowe M.C., Withers H.L., Swift S. Uropathogenic Escherichia coli forms biofilm aggregates under iron restriction that disperse upon the supply of iron. FEMS Microbiol. Lett. 2010, 307(1):102-109.
38. Russo T.A., Johnson J.R. Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development. Expert. Rev. Vaccines 2006, 5(1):45-54.
39. Russo T.A., McFadden C.D., Carlino-MacDonald U.B., Beanan J.M., Barnard T.J., Johnson J.R. IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect. Immun. 2002, 70(12):7156-7160.
40. Sambrook J., Russell D.W. Molecular Cloning a Laboratory Manual 2001, 3rd edition.
41. Schwyn B., Neilands J.B. Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 1987, 160(1):47-56.
42. Sorsa L.J., Dufke S., Heesemann J., Schubert S. Characterization of an iroBCDEN gene cluster on a transmissible plasmid of uropathogenic Escherichia coli: evidence for horizontal transfer of a chromosomal virulence factor. Infect. Immun. 2003, 71(6):3285-3293.
43. Wieser A., Romann E., Magistro G., Hoffmann C., Norenberg D., Weinert K., et al. A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice. Infect. Immun. 2010, 78(8):3432-3442.
44. Wieser A., Magistro G., Norenberg D., Hoffmann C., Schubert S. First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS). Int. J. Med. Microbiol. 2012, 302(1):10-18.
45. Yanisch-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 1985, 33(1):103-119.
46. Zhu M., Valdebenito M., Winkelmann G., Hantke K. Functions of the siderophore esterases IroD and IroE in iron-salmochelin utilization. Microbiology 2005, 151(Pt 7):2363-2372.